Back to Trexquant Investment LP Trexquant Investment LP

AXSMAXSM

Showing 6 of 19 quarters

Position history for Trexquant Investment LPTrexquant Investment LP's holdings in AXSOME THERAPEUTICS INC.

Yes. Trexquant Investment holds 83,679 shares of AXSM (Axsome Therapeutics), worth $20.5M, as of its Q2 2026 13F filing. It increased the position from 5,935 shares in Q1 2026. Trexquant Investment has held AXSM since Q3 2025, across 4 quarterly 13F filings. AXSM is 0.1% of Trexquant Investment's reported 13F portfolio.

Current Value

$20.5M

Current Shares

83,679

Total Value Change

+$19.3M

Total Shares Change

+69,550

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
83,679
+1309.9%
$20.5M0.1%$244.77
55
2026-Q1
Decreased
5,935
-87.9%
$1M0.0%$169.02
0
2025-Q4
Increased
49,136
+416.1%
$9M0.1%$182.64
44
2025-Q3
New
9,521
—
$1.2M0.0%$121.45
35
2025-Q1
Exited
0
-100.0%
$00.0%$116.63
0
2024-Q4
New
14,129
—
$1.2M0.0%$84.61
35

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used